Helmholtz Zentrum München receives EU funding for Lung Disease Project

In an attempt  to enhance the treatment regimen for infectious diseases worldwide, Helmholtz Zentrum München has received a funding for 3.9 million euros from the European Commission. The project is called "Cell2Cell Heterogeneity" and it will officially start from November 2019. This project will be funded for 4 years. This is a large collaborative project involving research institutions and Biotech companies.

For further information, please read the press release of Helmholtz Zentrum Munich